Bernhard Burian

634 total citations
13 papers, 489 citations indexed

About

Bernhard Burian is a scholar working on Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Bernhard Burian has authored 13 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Bernhard Burian's work include Pulmonary Hypertension Research and Treatments (4 papers), Neuropeptides and Animal Physiology (4 papers) and Peptidase Inhibition and Analysis (2 papers). Bernhard Burian is often cited by papers focused on Pulmonary Hypertension Research and Treatments (4 papers), Neuropeptides and Animal Physiology (4 papers) and Peptidase Inhibition and Analysis (2 papers). Bernhard Burian collaborates with scholars based in Austria, Switzerland and United States. Bernhard Burian's co-authors include Ventzislav Petkov, Karin Vonbank, L H Block, Leopold Stiebellehner, Georg‐Christian Funk, Rolf Ziesche, Wilhelm Mosgoeller, Clemens Novotny, Gerhard Hamilton and Markus Raderer and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and CHEST Journal.

In The Last Decade

Bernhard Burian

13 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard Burian Austria	10	280	160	80	69	55	13	489
Nobuharu Ohshima Japan	16	159 0.6×	59 0.4×	10 0.1×	49 0.7×	106 1.9×	56	566
Alpay Çakmak Türkiye	13	50 0.2×	25 0.2×	35 0.4×	77 1.1×	47 0.9×	37	425
Shinobu Sato Japan	12	127 0.5×	23 0.1×	28 0.3×	67 1.0×	30 0.5×	32	433
B. Baudin France	12	63 0.2×	135 0.8×	26 0.3×	137 2.0×	89 1.6×	27	454
E Ueda Japan	10	259 0.9×	60 0.4×	6 0.1×	57 0.8×	119 2.2×	31	441
Brigham Kl United States	11	252 0.9×	33 0.2×	14 0.2×	98 1.4×	100 1.8×	23	594
F Coste France	13	139 0.5×	53 0.3×	10 0.1×	100 1.4×	77 1.4×	34	379
Saif A. Muhsin United States	8	166 0.6×	24 0.1×	6 0.1×	126 1.8×	31 0.6×	13	500
Jakob Björk Sweden	11	42 0.1×	29 0.2×	21 0.3×	85 1.2×	64 1.2×	14	423
Akemi Takamizawa Japan	15	254 0.9×	17 0.1×	7 0.1×	71 1.0×	197 3.6×	24	662

Countries citing papers authored by Bernhard Burian

Since Specialization

Citations

This map shows the geographic impact of Bernhard Burian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Burian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Burian more than expected).

Fields of papers citing papers by Bernhard Burian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Burian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Burian. The network helps show where Bernhard Burian may publish in the future.

Co-authorship network of co-authors of Bernhard Burian

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Burian. A scholar is included among the top collaborators of Bernhard Burian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Burian. Bernhard Burian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Zeitlinger, Markus, Richard Schwameis, Bernhard Burian, et al.. (2016). Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid. Journal of Antimicrobial Chemotherapy. 71(4). 1022–1026. 55 indexed citations

2.

Storka, Angela, Bernhard Burian, Terri Sun, et al.. (2013). VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model. Journal of Translational Medicine. 11(1). 117–117. 8 indexed citations

3.

Lambers, Christopher, Michael Roth, Jun Zhong, et al.. (2013). The Interaction of Endothelin-1 and TGF-β1 Mediates Vascular Cell Remodeling. PLoS ONE. 8(8). e73399–e73399. 39 indexed citations

4.

Mautone, Giuseppe, Chiara Leuratti, Angelo Vaccani, et al.. (2013). An exploratory microdialysis study investigating the effect of repeated application of a diclofenac epolamine medicated plaster on prostaglandin concentrations in skeletal muscle after standardized physical exercise. British Journal of Clinical Pharmacology. 76(6). 880–887. 4 indexed citations

5.

Sauermann, Robert, Bernhard Burian, Walter Jäger, et al.. (2012). Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections. Journal of Antimicrobial Chemotherapy. 68(4). 895–899. 17 indexed citations

6.

Burian, Bernhard, et al.. (2012). Clinical Potential of VIP by Modified Pharmaco-kinetics and Delivery Mechanisms. Endocrine Metabolic & Immune Disorders - Drug Targets. 12(4). 344–350. 9 indexed citations

7.

Burian, Bernhard, et al.. (2011). Penetration of Doripenem into Skeletal Muscle and Subcutaneous Adipose Tissue in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 56(1). 532–535. 15 indexed citations

8.

Lambers, Christopher, et al.. (2010). Early immunomodulatory effects of linezolid in a human whole blood endotoxin model. International Journal of Clinical Pharmacology and Therapeutics. 48(7). 419–424. 16 indexed citations

9.

Burian, Bernhard, Angela Storka, Beatrice A. Marzluf, et al.. (2009). Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients. Peptides. 31(4). 603–608. 19 indexed citations

10.

Vonbank, Karin, Georg‐Christian Funk, Beatrice A. Marzluf, et al.. (2008). Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wiener klinische Wochenschrift. 120(23-24). 749–755. 30 indexed citations

11.

Burian, Bernhard, et al.. (2006). INHALED VASOACTIVE INTESTINAL PEPTIDE (VIP) IMPROVES THE 6-MINUTE WALK TEST AND QUALITY OF LIFE IN PATIENTS WITH COPD: THE VIP/COPD-TRIAL. CHEST Journal. 130(4). 121S–121S. 7 indexed citations

12.

Petkov, Ventzislav, Wilhelm Mosgoeller, Rolf Ziesche, et al.. (2003). Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. Journal of Clinical Investigation. 111(9). 1339–1346. 249 indexed citations

13.

Petkov, Ventzislav, Wilhelm Mosgoeller, Rolf Ziesche, et al.. (2003). Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. Journal of Clinical Investigation. 111(9). 1339–1346. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact